NCT04122560View on ClinicalTrials.gov

Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

November 30, 2019

Primary Completion Date

March 23, 2021

Study Completion Date

March 23, 2021

Conditions
FluconazoleCandidiasisInvasive Fungal InfectionsObesity
Interventions
DRUG

Fluconazole 200mg tab

PO dose of 400mg

DRUG

Fluconazole 2 MG/ML

IV dose of 400mg

Trial Locations (2)

Unknown

St. Antonius hospital, Nieuwegein

Radboudumc, Nijmegen

All Listed Sponsors
collaborator

St. Antonius Hospital

OTHER

lead

Radboud University Medical Center

OTHER

NCT04122560 - Fluconazole Pharmacokinetics, Including Bioavailability, in Obese Subjects After an Intravenous and Oral Administration | Biotech Hunter | Biotech Hunter